Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer

ANS Pharma

Status: Unknown

Conditions: Skin Diseases, Metabolic; Skin Care

Treatments: Other: Body moisturizer

Study type: Interventional

Funder types: Industry

Identifiers

NCT03192592

060935_01

Details and patient eligibility

About

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications.

Full description

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications. This study aim to address the target population, subjects with controlled diabetes, to verify the improvement of texture, elasticity, and general appearance of the skin through the application of the cosmetic product Apotech®.

Enrollment: 36 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with controlled diabetes
• Any phototype and all skin types

Exclusion criteria

• Pregnant women
• Subjects that not match the inclusion criteria

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

36 participants in 1 patient group

Body moisturizer Apotech®

Experimental group

Description:

Instructions for use: Massage the product in the body twice a day (morning and evening) with gentle movements until completely absorption. Daily use for 28 days.

Treatment:

Other: Body moisturizer